The Microbiome Therapeutics Innovation Group (MTIG) announced today the addition of Norwegian molecular diagnostic company Genetic Analysis AS to its coalition of companies leading the research and development of FDA-approved microbiome therapeutic drugs and microbiome-based products.
Please follow the link to read the full statement by MTIG: https://www.prnewswire.com/news-releases/genetic-analysis-joins-microbiome-therapeutics-innovation-group-301282013.html?tc=eml_cleartime